Edwards Lifesciences Corporation
EW · Healthcare · · USDFahodi Score BUY Long-term (Investment)
80
/ 100
Technical
100
Trend & RS
95
Momentum
74
Fundamental
89
Macro
24
Liquidity
88
| Component | Score | Weight |
|---|---|---|
| Technical | 100.0 | 10% |
| Trend & RS | 94.7 | 10% |
| Momentum | 74.3 | 5% |
| Fundamental | 88.9 | 40% |
| Macro | 23.8 | 15% |
| Liquidity | 87.5 | 20% |
Trade Setup
| Entry | 98.93 |
| Stop Loss | 93.05 (5.9%) |
| Target 1 (1:1) | 104.81 (+5.9%) |
| Target 2 (2:1) | 110.69 (+11.9%) |
| ATR(14) | 2.94 (3.0%) |
| Risk per Share | 5.88 |
| Reward:Risk | 2:1 |
ATR-based levels. Adjust for support/resistance zones.
Factor Profile
| Factor | Score | Z | Bar |
|---|---|---|---|
| Value | 21.3 | -1.15 | |
| Momentum | 74.3 | +0.97 | |
| Quality | 63.1 | +0.52 | |
| Composite | 52.9 | ||
Quality Scores
Piotroski F-Score
7
/9 —
Strong
✓
✓
✗
✗
✓
✓
✓
✓
✓
1. Positive Net Income
2. Positive Roa
3. Positive Cfo
4. Quality Earnings
5. Lower Leverage
6. Higher Liquidity
7. No Dilution
8. Higher Gross Margin
9. Higher Asset Turnover
Altman Z-Score
52.18
—
Safe Zone
Distress <1.81Grey 1.81–2.99>2.99 Safe
Valuation vs Peers Overvalued
| Metric | Stock | Sector | vs Peers |
|---|---|---|---|
| P/E Ratio | 58.6 | 22.0 | +166% above |
| P/B Ratio | 5.3 | 4.0 | Above |
| Dividend Yield | 0.0% | 1.5% | Below avg |
Comparing against Healthcare median multiples.
Trading at a premium to sector peers — verify growth justifies premium.
Intrinsic Value (DCF) Significantly Overvalued
Intrinsic Value
30.40
vs
Market Price
100.82
Upside
-69.8%
| Margin of Safety | -231.6% |
| Stage 1 PV (5yr FCF) | 4,122,348,919 |
| Terminal Value PV | 13,359,053,456 |
| Total Enterprise Value | 17,481,402,375 |
Assumptions
| Base FCF | 791,200,000 |
| Growth Rate (5yr) | 10.5% |
| Terminal Growth | 2.5% |
| Discount Rate (WACC) | 9.0% |
2-stage DCF: 5yr projected FCF + Gordon Growth terminal value. Estimates only — adjust growth and WACC for your own assumptions.
Position Sizing — Kelly Criterion
4.6%
Recommended Size
51.4%
Full Kelly
25.7%
Half Kelly
5.0%
Max Cap (Moderate)
Kelly inputs derived from quant score 80/100. Estimated win rate 64%, avg win 9.8%, avg loss 3.4%. Position was capped at the moderate risk maximum. This is analytical output, not a recommendation to trade.
RECOVERY
Regime: RECOVERY (40% confidence) — position size reduced 8%
Signal Summary STRONG BUY
4
Bullish Signals
0
Bearish Signals
68.56
RSI(14)
2.9331
MACD
Relative Strength (RS) STRONG RS
86
/ 99
RS Rating
✓ O'Neil PASS (≥80)
| RS vs SPY | ↑ RISING (+12.5% vs SPY 3M) |
| RS vs Sector | UNDERPERFORMING (Healthcare) |
| RS New High | ✓ RS at 3-month high Institutional accumulation signal |
| Sector Outperformance | -3.5% (3M) |
RS Line — stock / SPY (90 bars)
← older
newer →
RS vs SPY
50-day SMA of RS
STRONG RS:
Top performer — outperforming the market and making new relative highs. Institutional accumulation likely.
Technical Indicators
| Indicator | Value | Signal |
|---|---|---|
| Rsi | 68.56 | NEUTRAL |
| Macd | 2.9331 | BULLISH |
| Ma Cross | 88.86 / 85.76 | GOLDEN CROSS |
| Trend Short | ABOVE SMA50 | |
| Trend Long | ABOVE SMA200 | |
| Bollinger | MIDDLE | |
| Volume | 0.02x | LOW |
Key Levels
| Level | Price |
|---|---|
| 52-Week High | 104.17 |
| Bollinger Upper | 100.34 |
| SMA(200) | 85.76 |
| SMA(50) | 88.86 |
| SMA(20) | 91.15 |
| Current Price | 100.82 |
| Bollinger Lower | 81.97 |
| 52-Week Low | 74.66 |
| ATR(14) | 2.94 |
Advanced Technical Analysis
Click to expand
Wyckoff Phase & Volume Spread Analysis
Wyckoff Phase
Insufficient data for Wyckoff analysis.
Volume Spread Analysis (last 5 bars)
| Date | Signal | Vol | Description |
|---|---|---|---|
| 2026-11-02 | Normal | 2.75x | Normal bar — no special VSA pattern |
| 2026-11-03 | Normal | 1.48x | Normal bar — no special VSA pattern |
| 2026-11-04 | Normal | 1.79x | Normal bar — no special VSA pattern |
| 2026-11-05 | Normal | 2.09x | Normal bar — no special VSA pattern |
| 2026-11-06 | Normal | 0.02x | Normal bar — no special VSA pattern |
Ichimoku Cloud BULLISH
| Line | Value | Status |
|---|---|---|
| Tenkan-sen (9) | 96.03 | Above Kijun |
| Kijun-sen (26) | 93.30 | Base line |
| Senkou A | 94.67 | Leading span A |
| Senkou B | 93.30 | Leading span B |
| Cloud | 93.30 – 94.67 | Bullish (Green) |
| Price vs Cloud | 98.93 | Above Cloud |
| Chikou Span | 85.15 | Bullish |
| Alignment Score | 4/4 | BULLISH |
TTM Squeeze & Divergences
TTM Squeeze
SQUEEZE OFF
No squeeze
Momentum:
BULLISH FADING
BB: 81.97 – 100.34 | KC: 87.02 – 95.29
Divergences (last 60 bars)
| Type | Indicator | Bars Ago | Strength |
|---|---|---|---|
| Regular Bullish | RSI | 26 | |
| Hidden Bearish | RSI | 29 |
Anchored VWAP
VWAP: 85.73
Anchor: 2026-02-11 (52w Low)
ABOVE AVWAP
+15.4%
Heikin-Ashi Trend
BULLISH
Full data via /api/advanced/EW
Valuation
| Metric | Value |
|---|---|
| Market Cap | 57.97B |
| P/E (TTM) | 58.62 |
| Forward P/E | N/A |
| P/B | 5.34 |
| EPS | 1.72 |
Financial Health
| Metric | Value |
|---|---|
| Revenue Growth | 10.5% |
| Profit Margin | 15.3% |
| ROE | 9.3% |
| Debt/Equity | 6.43 |
| Current Ratio | 4.60 |
| Dividend Yield | N/A |
| Payout Ratio | N/A |
| Beta | 0.83 |
Trading Data
100.82
Open
100.82
Day High
100.82
Day Low
9.15M
Volume (2.5x avg)
Price Chart (90 Days)
Candlesticks (green=up, red=down)
SMA 20
SMA 50
Bollinger Bands (upper/lower)
Volume (green=buying, red=selling)